Judgment of the Court (Fourth Chamber) of 25 March 2021
Sun Pharmaceutical Industries Ltd and Ranbaxy (UK) Ltd v European Commission
Appeal – Competition – Agreements, decisions and concerted practices – Pharmaceutical products – Market for antidepressant medicines (citalopram) – Settlement agreements concerning process patents concluded between a manufacturer of originator medicines holding those patents and manufacturers of generic medicines – Article 101 TFEU – Potential competition – Restriction by object – Characterisation – Calculation of the amount of the fine
Case C-586/16 P
Reports of Cases
Not yet published (General Report - Section 'Information on unpublished decisions')
Links to the texts
|
Curia |
EUR-Lex |
Autres Liens |
Judgment
ECLI:EU:C:2021:241 |
|
|
|